swertisin has been researched along with Alloxan Diabetes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, G; Gupta, S; Murumkar, P; Pappachan, A; Patel, D; Shah, H; Shah, R; Srivastava, A; Vakani, M | 1 |
| Akbar, S; Dar, SA; Ganai, BA; Ghazanfar, K; Hameed, I; Masood, A; Mubashir, K; Nazir, T | 1 |
| Bhatt, LK; Khanna, A; Mokashi, P; Pandita, N | 1 |
| Dadheech, N; Gupta, S; Srivastava, A; Vakani, M | 1 |
| Mishra, SH; Patel, MB | 1 |
5 other study(ies) available for swertisin and Alloxan Diabetes
| Article | Year |
|---|---|
Swertisin, a novel SGLT2 inhibitor, with improved glucose homeostasis for effective diabetes therapy.
Topics: Animals; Apigenin; Caco-2 Cells; Computer Simulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; HEK293 Cells; Homeostasis; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Kidney; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Phytotherapy; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Gentiana kurroo Royle attenuates the metabolic aberrations in diabetic rats; Swertiamarin, swertisin and lupeol being the possible bioactive principles.
Topics: Animals; Apigenin; Biomarkers; Diabetes Mellitus, Experimental; Female; Gentiana; Hypoglycemic Agents; Insulin-Secreting Cells; Iridoid Glucosides; Male; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Pyrones; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2017 |
Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Topics: Animals; Antioxidants; Apigenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavonoids; Gentianaceae; Glucose; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Plant Extracts; Rats; Streptozocin | 2017 |
Swertisin ameliorates diabetes by triggering pancreatic progenitors for islet neogenesis in Streptozotocin treated BALB/c mice.
Topics: Animals; Apigenin; Cell Differentiation; Diabetes Mellitus, Experimental; Female; Hypoglycemic Agents; Insulin; Islets of Langerhans; Mice, Inbred BALB C; Stem Cells; Streptozocin | 2018 |
Hypoglycemic activity of C-glycosyl flavonoid from Enicostemma hyssopifolium.
Topics: Aldehyde Reductase; Animals; Apigenin; Blood Glucose; Cell Line, Tumor; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Experimental; Female; Gentianaceae; Gluconeogenesis; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Iridoid Glucosides; Male; Phytotherapy; Plant Components, Aerial; Plant Extracts; Pyrones; Rats; Rats, Wistar | 2011 |